Utilities Registry

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Valuation

Population

Condition

Viewing 1 - 10 of 44 results

Title	Year(s) of data collection	Valuation Method	Country	Condition
Selection of neurological disease health state utilities (Looby A et al., J Med Econ. 2023. doi:10.1080/13696998.2023.2189395)	2022	EQ-5D-5L	United Kingdom of Great Britain and Northern Ireland	Spinal cord injury
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics A cohort of 57 patients with spinal cord injury
Title Selection of COVID-19 health state utilities (Philip KEJ et al. Lancet Respir Med. 2022. doi:10.1016/S2213-2600(22)00125-4)	Year(s) of data collection 2021	Valuation Method SF-6D	Country United Kingdom of Great Britain and Northern Ireland	Condition COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 150 people in RCT of breathing and wellbeing programme for people with persistent symptoms following COVID-19
Title Selection of COVID-19 health state utilities (Chakravarty R et al., Indian J Psychol Med. 2023. doi:10.1177/02537176221140557)	Year(s) of data collection 2021	Valuation Method EQ-5D-5L	Country India	Condition COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 80 COVID-19 patients treated with single infusion tocilizumab or no treatment
Title Selection of COVID-19 health state utilities (Shah C et al., Lung India. 2023. doi:10.4103/lungindia.lungindia_126_22)	Year(s) of data collection 2021	Valuation Method EQ-5D-3L	Country India	Condition COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 388 patients with confirmed COVID-19 who had been treated and discharged after hospitalization
Title Selection of oncology health state utilities (Cooper OAE et al., Pharmacoecon Open. 2023. doi:10.1007/s41669-023-00392-4)	Year(s) of data collection 2021	Valuation Method EQ-5D-5L	Country United Kingdom of Great Britain and Northern Ireland	Condition Invasive bladder cancer
DOI 10.7910/DVN/L4V2LU Author(s) Registry, Utilities Description Health state utilities for oncology conditions Sample Characteristics 202 individuals from UK general public
Title Selection of general population health health state utilities (Nikl A et al., Health Qual Life Outcomes. 2023. doi:10.1186/s12955-023-02096-z)	Year(s) of data collection 2021	Valuation Method 15D, EQ-5D-5L	Country Hungary	Condition General population health
DOI 10.7910/DVN/OE5E2K Author(s) Registry, Utilities Description Health state utilities for general population health conditions Sample Characteristics 1887 participants in the online cross-sectional survey
Title Selection of general population health health state utilities (Zhang W et al., Haemophilia. 2022. doi:10.1111/hae.14615)	Year(s) of data collection 2021	Valuation Method SF-6Dv2	Country China	Condition General population health, Haemophilia
DOI 10.7910/DVN/OE5E2K Author(s) Registry, Utilities Description Health state utilities for general population health conditions Sample Characteristics 206 age and gender matched sample of the general population with people with haemophilia
Title Selection of autoimmune disease health state utilities (Dewilde S et al., Adv Ther. 2023. doi:10.1007/s12325-023-02437-w)	Year(s) of data collection 2021	Valuation Method EQ-5D-5L, HUI3	Country Belgium, Canada, Denmark, France, Germany, Italy, Japan, Netherlands, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America	Condition Myasthenia gravis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics 9000 participants in the general population norms study that included adult patients with gMG randomly assigned to treatment with efgartigimod or conventional therapy
Title Selection of orthopedic and musculoskeletal health state utilities (Eguchi Y et al., Pain Ther. 2023. doi:10.1007/s40122-022-00472-z)	Year(s) of data collection 2021 - 2022	Valuation Method EQ-5D-5L	Country Japan	Condition Lumbar spinal stenosis with low back pain
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics A multicenter, randomized, active-controlled, open-label trial of 64 patients diagnosed with LSS by MRI to examine the clinical efficacy of neurotropin for lumbar spinal stenosis with low back pain
Title Selection of COVID-19 health state utilities (Rosa RG et al., Intensive Care Med. 2023. doi:10.1007/s00134-022-06953-1)	Year(s) of data collection 2020 - 2022	Valuation Method EQ-5D-3L	Country Brazil	Condition COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 1156 adults post-hospitalization COVID-19 patients

Next results →